Evaluation of the Diabetes Regional Coordination Path using the Diabetes Coordination Notebook in community-based diabetes care.

Diabetes Coordination Notebook Diabetes Regional Coordination Path Diabetic Eye Notebook Periodontal disease Questionnaire Retinopathy

Journal

Diabetology international
ISSN: 2190-1678
Titre abrégé: Diabetol Int
Pays: Japan
ID NLM: 101553224

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 10 07 2018
accepted: 12 10 2018
entrez: 6 7 2019
pubmed: 6 7 2019
medline: 6 7 2019
Statut: epublish

Résumé

A number of epidemiologic surveys have demonstrated that improving lifestyle habits, providing patient education, and regular screening of patients for early diabetic symptoms and complications through multidisciplinary collaboration are crucial for the management of diabetes. To evaluate the Diabetes Coordination Notebook and the Diabetes Regional Coordination Path in management of diabetes, 217 community pharmacies conducted a survey by questionnaire in Gifu Prefecture, Japan. A reply to the questionnaire was obtained from 27,016 individuals, of whom 5,572 claimed to have diabetes or prediabetes. The rate of usage of the Diabetes Coordination Notebook and the Diabetes Regional Coordination Path was 40% and 7%, respectively. Interestingly, patients using the Diabetes Regional Coordination Path more frequently visited an ophthalmic clinic ( The usage of the Diabetes Regional Coordination Path together with the Diabetes Coordination Notebook is associated not only with regular visits to both an ophthalmic clinic and a dental clinic but also with the maintenance of appropriate HbA1c.

Identifiants

pubmed: 31275785
doi: 10.1007/s13340-018-0379-6
pii: 379
pmc: PMC6592995
doi:

Types de publication

Journal Article

Langues

eng

Pagination

188-197

Déclaration de conflit d'intérêts

Conflict of interestAll authors report no conflicts of interest relevant to this article.

Références

Diabetes Care. 1999 Jul;22(7):1125-36
pubmed: 10388978
Arch Intern Med. 1999 Sep 13;159(16):1873-80
pubmed: 10493317
J Diabetes Complications. 2000 Jan-Feb;14(1):18-24
pubmed: 10925062
Value Health. 2001 Sep-Oct;4(5):392-400
pubmed: 11705130
Diabetologia. 2002 Jul;45(7):S13-7
pubmed: 12136406
Lancet. 2003 Jan 18;361(9353):195-200
pubmed: 12547541
N Engl J Med. 2003 Jan 30;348(5):383-93
pubmed: 12556541
J Dent Res. 2004 Jun;83(6):485-90
pubmed: 15153457
N Engl J Med. 2005 Dec 22;353(25):2643-53
pubmed: 16371630
J Clin Periodontol. 2006 Jun;33(6):408-14
pubmed: 16677329
BMJ. 2007 Feb 10;334(7588):299
pubmed: 17237299
Diabetes Care. 2008 Jan;31(1):99-101
pubmed: 17934144
J Oral Rehabil. 2008 Mar;35(3):218-23
pubmed: 18254800
N Engl J Med. 2008 Oct 9;359(15):1577-89
pubmed: 18784090
Diabetologia. 1991 Mar;34(3):164-70
pubmed: 1884887
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
J Diabetes Complications. 2010 Nov-Dec;24(6):409-14
pubmed: 19628414
Patient Educ Couns. 2010 Jul;80(1):29-41
pubmed: 19906503
Diabetologia. 2011 May;54(5):1025-31
pubmed: 21286682
Diabetes Educ. 2012 Jan-Feb;38(1):108-23
pubmed: 22116473
Diabetes Care. 2013 Aug;36(8):2271-9
pubmed: 23418368
Diabetes Care. 2013 Apr;36(4):1033-46
pubmed: 23468086
Lancet Diabetes Endocrinol. 2014 Jan;2(1):56-64
pubmed: 24622669
N Engl J Med. 2014 May 22;370(21):2002-13
pubmed: 24679060
J Diabetes Investig. 2013 Sep 13;4(5):460-5
pubmed: 24843696
Intern Med. 2014;53(14):1491-6
pubmed: 25030559
PLoS One. 2016 Jul 20;11(7):e0159071
pubmed: 27437997
J Diabetes. 2017 Apr;9(4):320-324
pubmed: 28070960
Diabetes. 1986 May;35(5):530-45
pubmed: 2869996
Diabetes Res Clin Pract. 1995 May;28(2):103-17
pubmed: 7587918
N Engl J Med. 1993 Sep 30;329(14):977-86
pubmed: 8366922

Auteurs

Yukio Horikawa (Y)

1Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194 Japan.

Akio Suzuki (A)

2Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194 Japan.

Ken-Ichi Hashimoto (KI)

1Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194 Japan.

Mayumi Enya (M)

1Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194 Japan.

Shohei Nishida (S)

2Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194 Japan.

Ryo Kobayashi (R)

2Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194 Japan.

Tetsuya Ohashi (T)

Gifu Pharmaceutical Association, 4-5 Kokonoecho, Gifu, 500-8146 Japan.

Futoshi Yamazaki (F)

Gifu Pharmaceutical Association, 4-5 Kokonoecho, Gifu, 500-8146 Japan.

Rieko Totani (R)

4Gifu Prefecture Medical Association, 3-5-1 Yabutaminami, Gifu, 500-8510 Japan.

Hiroshi Kobayashi (H)

4Gifu Prefecture Medical Association, 3-5-1 Yabutaminami, Gifu, 500-8510 Japan.

Mayumi Yamamoto (M)

5Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1194 Japan.

Yoshinori Itoh (Y)

2Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, 501-1194 Japan.

Jun Takeda (J)

1Department of Diabetes and Endocrinology, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu, 501-1194 Japan.

Classifications MeSH